5-氯-2-硝基苯硼酸 | 532924-25-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-氯-2-硝基苯硼酸
• 英文名称: (5-chloro-2-nitrophenyl)boronic acid
• 英文别名: 5-Chloro-2-nitrophenylboronic acid
• CAS: 532924-25-7
• 化学式: C₆H₅BClNO₄
• 分子量: 201.374
• InChiKey: PURYLRLRXKALOG-UHFFFAOYSA-N

物化性质

• 沸点：
  409.0±55.0 °C(Predicted)
• 密度：
  1.54±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.07
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  86.3
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2931900090
• 危险性防范说明：
  P501,P270,P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313,P301+P312+P330
• 危险性描述：
  H302,H315,H319

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Chloro-2-nitrophenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Chloro-2-nitrophenylboronic acid
CAS number: 532924-25-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H5BClNO4
Molecular weight: 201.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-氯-2-硝基苯硼酸 在 四(三苯基膦)钯 、 potassium carbonate 、 三苯基膦 作用下， 以 四氢呋喃 、 水 、 邻二氯苯 为溶剂， 反应 24.0h， 生成 7-chloro-3-phenyl-3,10-dihydropyrrolo[3,2-a]carbazole
  参考文献：
  名称：

  유기 화합물 및 이를 포함하는 유기 전계 발광 소자

  摘要：

  本发明涉及一种新化合物及其包含的有机电致发光器件，根据本发明，该化合物可用于有机电致发光器件的有机层，特别是发光层、载流子传输层、电子阻挡层或发光辅助层，从而可以提高有机电致发光器件的发光效率、驱动电压、寿命等性能。

  公开号：

  KR20150038811A

文献信息

• Palladium-catalyzed Suzuki–Miyaura reaction of fluorinated vinyl chloride: a new approach for synthesis α and α,β-trifluoromethylstyrenes
  作者：Yang Li、Bo Zhao、Kun Dai、Dong-Huai Tu、Bo Wang、Yao-Yu Wang、Zhao-Tie Liu、Zhong-Wen Liu、Jian Lu

  DOI：10.1016/j.tet.2016.07.085

  日期：2016.9

  A mild and efficient palladium-catalyzed cross-coupling between fluorinated vinyl chloride and arylboronic acids is described. The use of ligand B successfully overcomes the strong electronic withdrawing of trifluoromethylated substrates and allows the efficient synthesis of a wide range of α and α,β-trifluoromethyl containing olefins. By using this method, the key intermediate for synthesis of Efavirenz

  描述了氟化氯乙烯与芳基硼酸之间温和有效的钯催化的交叉偶联。配体B的使用成功地克服了三氟甲基化底物的强电子吸出，并允许有效合成范围广泛的含α和α，β-三氟甲基的烯烃。通过这种方法，可以通过简单的途径获得合成依非韦伦的关键中间体。将两个氟利昂分子有效转化为有用的含α和α，β-三氟甲基的烯烃是有机化学中的有用途径。
• [EN] FACTOR XIA INHIBITORS<br/>[FR] INHIBITEURS DU FACTEUR XIA
  申请人：MERCK SHARP & DOHME

  公开号：WO2015183709A1

  公开（公告）日：2015-12-03

  The present invention provides a compound of Formula I(The chemical formula should be inserted here.) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

  本发明提供了一种I式化合物（化学式应在此处插入），以及包括一种或多种所述化合物的药物组合物，并且使用所述化合物用于治疗或预防血栓、栓塞、高凝血性或纤维变化的方法。这些化合物是选择性因子XIa抑制剂或因子XIa和血浆激肽原的双重抑制剂。
• ORGANIC ELECTROLUMINESCENCE DEVICE AND CONDENSED CYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
  申请人：Samsung Display Co., Ltd.

  公开号：US20200052224A1

  公开（公告）日：2020-02-13

  Provided is an organic electroluminescence device including a first electrode, a hole transport region disposed on the first electrode, an emission layer disposed on the hole transport region, an electron transport region disposed on the emission layer, and a second electrode disposed on the electron transport region, in which the hole transport region includes a condensed cyclic compound, thereby securing high emission efficiency.

  提供一个有机电致发光装置，包括第一电极、位于第一电极上的空穴传输区域、位于空穴传输区域上的发射层、位于发射层上的电子传输区域以及位于电子传输区域上的第二电极，其中空穴传输区域包括一个缩环化合物，从而确保高的发射效率。
• [EN] 1-PHENYLPYRROLE COMPOUNDS<br/>[FR] 1-PHÉNYLPYRROLES
  申请人：EXELIXIS INC

  公开号：WO2010042626A1

  公开（公告）日：2010-04-15

  The present invention comprises a compound for the prevention and/or treatment of cardiovascular diseases, nephropathy, fibrosis, primary aldosteronism or edema. The compound is of the following general formula (I): wherein R1 represents a C1 -C3 alkyl group; R2 represents a hydroxy -C1 -C4 alkyl group and the like; R3 represents a halogeno group, a halogeno-C1 -C3 alkyl group and the like; R4 represents a hydrogen atom, a halogeno group and the like,- R5 represents a sulfamoyl group or a C1-C3 alkylsulf onyl group; R6 represents a hydrogen atom, a halogeno group and the like] or an N-oxide, atropisomer of the foregoing, or pharmaceutically acceptable salt of the foregoing.

  本发明涉及一种用于预防和/或治疗心血管疾病、肾病、纤维化、原发性醛固酮分泌亢进或水肿的化合物。该化合物具有以下一般式（I）：其中R1代表C1-C3烷基基团；R2代表一个羟基-C1-C4烷基基团等；R3代表一个卤素基团，一个卤素-C1-C3烷基基团等；R4代表一个氢原子，一个卤素基团等；R5代表一个磺胺基团或一个C1-C3烷基磺酰基团；R6代表一个氢原子，一个卤素基团等，或者上述化合物的N-氧化物、旋光异构体或上述化合物的药用可接受的盐。
• [EN] FACTOR XIa INHIBITORS<br/>[FR] INHIBITEURS DU FACTEUR XIA
  申请人：MERCK SHARP & DOHME

  公开号：WO2016018701A1

  公开（公告）日：2016-02-04

  The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

  本发明提供了一种化合物的化学式（I），以及包含一种或多种所述化合物的药物组合物，并使用所述化合物治疗或预防血栓、栓塞、高凝状态或纤维变化的方法。这些化合物是选择性因子XIa抑制剂或同时抑制因子XIa和血浆激肽酶的双重抑制剂。